Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNH3 | Q9ULD8 | 2/20 | 0.65 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.59 |
| ▸ | MAPT | P10636 | 5/20 | 0.59 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.50 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.50 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.50 |
| ▸ | HTR2B | P41595 | 1/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
| ▸ | EPHX1 | P07099 | 3/20 | 0.47 |
| ▸ | GAA | P10253 | 2/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
| ▸ | HPGD | P15428 | 2/20 | 0.47 |
| ▸ | ABL1 | P00519 | 1/20 | 0.46 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1850990 | 0.98 | KCNH3 (0.63) | KCNH3ALDH1A1MAPTALOX12HSD17B10 | |
| SCHEMBL1851675 | 0.98 | KCNH3 (0.63) | KCNH3ALDH1A1MAPTALOX12HSD17B10 | |
| SCHEMBL809968 | 0.98 | KCNH3 (0.63) | KCNH3ALDH1A1MAPTALOX12HSD17B10 | |
| SCHEMBL809713 | 0.98 | KCNH3 (0.63) | KCNH3ALDH1A1MAPTALOX12HSD17B10 | |
| SCHEMBL809599 | 0.98 | KCNH3 (0.63) | KCNH3ALDH1A1MAPTALOX12HSD17B10 | |
| SCHEMBL1851794 | 0.98 | KCNH3 (0.63) | KCNH3ALDH1A1MAPTALOX12HSD17B10 | |
| SCHEMBL1849170 | 0.94 | ALDH1A1 (0.61) | KCNH3ALDH1A1MAPTALOX12HSD17B10 | |
| SCHEMBL96273 | 0.92 | ALDH1A1 (0.70) | KCNH3ALDH1A1MAPTL3MBTL1EPHX1 | |
| SCHEMBL177298 | 0.90 | ALDH1A1 (0.67) | KCNH3ALDH1A1MAPTL3MBTL1EPHX1 | |
| SCHEMBL1014213 | 0.90 | ALDH1A1 (0.67) | KCNH3ALDH1A1MAPTL3MBTL1EPHX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 78 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8062551-B2 | Antiozonant blends | CHEMTURA CORPORATION (US) | 2011-11-22 | — | — | US | claimed |
| EP-2013273-B1 | ANTIOZONANT BLENDS | CHEMTURA CORP (US) | 2011-11-16 | — | — | EP | claimed |
| WO-2011130994-A1 | MULTI-USER CHANNEL ESTIMATION METHOD AND DEVICE | 中兴通讯股份有限公司 (CN) | 2011-10-27 | — | — | WO | claimed |
| EP-1976821-B1 | DIRECT ALKYLATION OF N-ALKYL-N'-PHENYL-P-PHENYLENEDIAMINE | CHEMTURA CORP (US) | 2011-05-25 | — | — | EP | claimed |
| EP-2013273-A1 | ANTIOZONANT BLENDS | CHEMTURA CORPORATION (US) | 2009-01-14 | — | — | EP | claimed |
| EP-1976821-A1 | DIRECT ALKYLATION OF N-ALKYL-N'-PHENYL-P-PHENYLENEDIAMINE | CHEMTURA CORPORATION (US) | 2008-10-08 | — | — | EP | claimed |
| US-7361788-B2 | Direct alkylation of N-alkyl-N′-phenyl-p-phenylenediamine | CHEMTURA CORPORATION (US) | 2008-04-22 | — | — | US | claimed |
| WO-2007130262-A1 | ANTIOZONANT BLENDS | CHEMTURA CORPORATION (US) | 2007-11-15 | — | — | WO | claimed |
| US-20070260000-A1 | Antiozonant blends | ADDIVANT USA, LLC | 2007-11-08 | — | — | US | claimed |
| WO-2007087195-A1 | DIRECT ALKYLATION OF N-ALKYL-N'-PHENYL-P-PHENYLENEDIAMINE | CHEMTURA CORPORATION (US) | 2007-08-02 | — | — | WO | claimed |
| US-20070173668-A1 | Direct alkylation of N-alkyl-N'-phenyl-p-phenylenediamine | LANXESS SOLUTIONS US INC. | 2007-07-26 | — | — | US | claimed |
| EP-1056711-B1 | PROCESS FOR STABILISING (METHA)ACRYLIC ESTERS AGAINST UNWANTED RADICAL POLYMERISATION | BASF AG (DE) | 2004-10-06 | — | — | EP | claimed |
| EP-4028382-B1 | QUINONE METHIDE AND AMMONIUM SALT ANTIPOLYMERANT COMPOSITION AND METHOD | ECOLAB USA INC (US) | 2023-11-22 | — | — | EP | disclosed |
| US-11396629-B2 | Quinone methide and ammonium salt antipolymerant composition and method | ECOLAB USA INC. (US) | 2022-07-26 | — | — | US | disclosed |
| US-20210108141-A1 | QUINONE METHIDE AND AMMONIUM SALT ANTIPOLYMERANT COMPOSITION AND METHOD | ECOLAB USA INC. | 2021-04-15 | — | — | US | disclosed |
| EP-3680231-A1 | METHOD FOR THE PREPARATION OF N-ISOPROPYL(METH)ACRYLAMIDE | Evonik Operations GmbH (DE) | 2020-07-15 | — | — | EP | disclosed |
| EP-0266906-A2 | Method and composition for inhibiting acrylate ester polymerization | BETZ EUROPE, INC. (US) | 1988-05-11 | — | — | EP | disclosed |
| US-4720566-A | Method and composition for inhibiting acrylonitrile polymerization | BETZ LABORATORIES, INC. (US) | 1988-01-19 | — | — | US | disclosed |
| US-4051067-A | Stabilization of unsaturated carboxylic acid esters with mixtures of polyalkyleneamines and arylenediamines | MONSANTO COMPANY (US) | 1977-09-27 | — | — | US | disclosed |
| US-4016198-A | Stabilization of unsaturated carboxylic acid esters with mixtures of polyalkylene-amines and arylenediamines | MONSANTO COMPANY (US) | 1977-04-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070173668-A1 | Direct alkylation of N-alkyl-N'-phenyl-p-phenylenediamine | PNMT, AAAS, PNN | KCNH3 488/4885ALDH1A1 663/4885MAPT 2244/4885 |
| US-11396629-B2 | Quinone methide and ammonium salt antipolymerant composition and method | SQOR, QDPR, NQO2 | KCNH3 953/4885ALDH1A1 961/4885MAPT 1275/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.